The present status of chemotherapy in dermatology.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D001380:Azauridine / Q000008:administration & dosage / Q000627:therapeutic use; D010478:Chemotherapy, Cancer, Regional Perfusion; D004358:Drug Therapy; D005493:Folic Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007269:Injections, Intra-Arterial; D009946:Organothiophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use; D011687:Purines / Q000008:administration & dosage / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D009946:Organothiophosphorus Compounds; D011687:Purines; D011743:Pyrimidines; D011344:Procarbazine; D001380:Azauridine; D001379:Azathioprine